DANNY MAYS: Open Payments
NPI 1740201672 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 23 payments from 16 companies in 2025. Trend: 2023 $626 · 2024 $750 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Novo Nordisk Inc | 3 | $70 |
| Viatris Specialty LLC | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| PFIZER INC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $22 |
Products named: AIRSUPRA, Ozempic, YUPELRI, REXULTI, XIFAXAN, PLUVICTO, INJECTAFER, PREVNAR 20.
Industry payments across NM — which companies pay providers there.
